Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: Treatment with thrombolysis

American Journal of Hematology

Volumn 83, Issue 10, 2008, Pages 818-820

  Sidani, Charit A ^a   Ballourah, Walid ^a   El Dassouki, Mohamad ^b   Muwakkit, Samar ^a   Dabbous, Ibrahim ^a   Dahoui, Hanan ^a   Al Kutoubi, Aghiad ^a   Abboud, Miguel R ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYUREA; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; AVASCULAR NECROSIS; BLEEDING; BLOOD TRANSFUSION; BRAIN INFARCTION; CASE REPORT; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL SINUS; FIBRINOLYTIC THERAPY; HEMOGLOBIN BLOOD LEVEL; HIP DISEASE; HUMAN; HYPERCOAGULABILITY; MALE; PHLEBOTOMY; PRIORITY JOURNAL; RIGHT SIGMOID DURAL SINUS; RIGHT TRANSVERSE SINUS; SICKLE CELL ANEMIA; SIDE EFFECT; STROKE; SUPERIOR SAGITTAL SINUS;

ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BRAIN INFARCTION; DURA MATER; FOLLOW-UP STUDIES; HEMOGLOBINS; HIP; HOMOZYGOTE; HUMANS; HYDROXYUREA; MALE; OSTEONECROSIS; SINUS THROMBOSIS, INTRACRANIAL; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 53549105005     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21261     Document Type: Article

References (21)

1. Ciurea SO, Thulborn KR, Gowhari M. Dural venous sinus thrombosis in a patient with sickle cell disease: Case report and literature review. Am J Hematol 2006;81:290-293.
2. Di Roio C, Jourdan C, Terrier A, Artru F. Drepanocytose et thrombose des veines cerebrales internes. Ann Fr Anesth Reanim 1997;16:967-969.
3. Oguz M, Aksungur EH, Soyupak SK, Yildirim AU. Vein of Galen and sinus thrombosis with bilateral thalamic infarcts in sickle cell anemia: CT follow-up and angiographic demonstration. Neuroradiology 1994;36:155-156.
4. van Mierlo TD, van den Berg HM, Nievelstein RAJ, Braun KPJ. An unconscious girl with sickle cell disease. Lancet 2003;361:136.
5. Sebire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: Risk factors, presentation, diagnosis and outcome. Brain 2005;128:477-489.
6. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791-1798.
7. Kirkham FJ. Therapy insight: Stroke risk and its management in patients with sickle cell disease. Nat Clin Pract Neurol 2007;3:264-278.
8. Wasay M, Dai AI, Ansari M, et al. Cerebral venous sinus thrombosis in children: A multicenter cohort from the United States. J Child Neurol 2008;23:26-31.
9. Schenck EA. Sickle cell trait and superior longitudinal sinus thrombosis. Ann Intern Med 1964;60:465-470.
10. Feldenzer JA, Bueche MJ, Venes JL, Gebarski SS. Superior sagittal sinus thrombosis with infarction in sickle cell trait. Stroke 1987;18:656-660.
11. Milner PF, Kraus AR Sebes JI, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991;325:1476-1481.
12. Johnson CS. Arterial blood pressure and hyperviscosity in sickle cell disease. Hematol Oncol Clin N Am 2005;19:827-837.
13. Charache S, de la Monte S, Macdonald V. Increased blood viscosity in a patient with sickle cell anemia. Blood Cells 1982;8:103-109.
14. Ballas SK, Dover GJ, Charache S. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo. Am J Hematol 1989;32:104-111.
15. Gambero S, Canalli AA, Traina F, et al. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties. Eur J Hematol 2007;78:144-151.
16. Styles LA, Lubin B, Vichinsky E, et al. Decrease of very late activation antigen4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 1997;89:2554-2559.
17. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007;110:908-912.
18. Stein PD, Beemath A, Meyers FA, et al. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 2006;119:897e7-897e11.
19. Stam J, De Bruijin SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002;4:CD002005.
20. Kenet G, Kirkham F, Niederstadt T, et al. Risk factors for recurrent venous thromboembolism in the European collaborative pediatric database on cerebral venous thrombosis: A multicentre cohort study. Lancet Neurol 2007;6:595-603.
21. Ciccone A, Canhao P, Falcao F, et al. Thrombolysis for cerebral vein and dural sinus thrombosis (review). Cochrane Database Syst Rev 2004;1:CD003693.